Prognostic value of undetectable hs troponin T in suspected acute coronary syndrome

Background - The search for improved strategies for safe and early discharge of patients with suspected acute coronary syndrome in emergency departments is ongoing. This Biomarkers in Cardiology (BIC)-8 biomarker substudy evaluated the usefulness of high-sensitivity troponin T (hsTnT) below or above...

Full description

Saved in:
Bibliographic Details
Main Authors: Vafaie, Mehrshad (Author) , Slagman, Anna (Author) , Möckel, Martin (Author) , Hamm, Christian (Author) , Huber, Kurt (Author) , Müller, Christian (Author) , Vollert, Jörn O. (Author) , Blankenberg, Stefan (Author) , Katus, Hugo (Author) , Liebetrau, Christoph (Author) , Giannitsis, Evangelos (Author) , Searle, Julia (Author)
Format: Article (Journal)
Language:English
Published: [2016]
In: The American journal of medicine
Year: 2016, Volume: 129, Issue: 3, Pages: 274-282, 282.e1-282.e2
ISSN:1555-7162
DOI:10.1016/j.amjmed.2015.10.016
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.amjmed.2015.10.016
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0002934315010207
Get full text
Author Notes:Mehrshad Vafaie, Anna Slagman, Martin Möckel, Christian Hamm, Kurt Huber, Christian Müller, Jörn O. Vollert, Stefan Blankenberg, Hugo A. Katus, Christoph Liebetrau, Evangelos Giannitsis, Julia Searle
Description
Summary:Background - The search for improved strategies for safe and early discharge of patients with suspected acute coronary syndrome in emergency departments is ongoing. This Biomarkers in Cardiology (BIC)-8 biomarker substudy evaluated the usefulness of high-sensitivity troponin T (hsTnT) below or above the limit of detection (LoD) in low-to-intermediate-risk patients with suspected acute coronary syndrome in the emergency department. - Methods - Patients were categorized into hsTnT ≥ the 99th percentile, between the 99th percentile and LoD, or undetectable hsTnT (<LoD). HsTnT and copeptin were measured at admission, using a copeptin cut-off of 10 pmol/L. The primary endpoint was death and myocardial infarction within 90 days after admission. - Results - Of 882 patients with all biomarker results, 577 (65.4%) had detectable hsTnT levels (≥LoD). Among the 305 patients (34.6%) with undetectable hsTnT, no myocardial infarctions or deaths occurred within 90 days. In patients with detectable hsTnT at admission (≥LoD but ≤99th percentile), the combined endpoint occurred in 1.5% (6/410) of the copeptin-negative patients and in 6.3% (6/96) of copeptin-positive patients within 90 days (hazard ratio 4.39; 95% confidence interval, 1.42-13.61; P = .01). In patients with an initially elevated hsTnT (≥14 ng/L), 9.7% (3/31) of the copeptin-negative patients and 15.4% (4/26) of the copeptin-positive patients experienced the combined endpoint (hazard ratio 1.61; 95% confidence interval, 0.36-7.17; P = .536). - Conclusions - In low-to-intermediate-risk patients with suspected acute coronary syndrome, undetectable hsTnT values at admission allow a safe discharge without occurrence of death or myocardial infarction within 90 days.
Item Description:Gesehen am 29.05.2020
Physical Description:Online Resource
ISSN:1555-7162
DOI:10.1016/j.amjmed.2015.10.016